Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

Fill Out & Get More Relevant News

Your name

Your email

Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.
Popular
- House DOGE subcommittee chair Greene threatens criminal referrals over foreign aid spending
  February 27, 2025
- Top conservative group vows to ‘work closely’ with Trump on 2026 GOP primaries despite past clashes
  February 27, 2025

House DOGE subcommittee chair Greene threatens criminal referrals over foreign aid spending